Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2023
February 23 - 25, 2023; San Diego, California
February 23 - 25, 2023San Diego, California
ACTRIMS 2023New Digital Tools Promising in MSNext generation wearable devices that measure function with a high degree of precision promise to detect earlier changes in multiple sclerosis and differentiate between different subtypes of MS.
Medscape Medical News, March 3, 2023
ACTRIMS 2023Cutting Calories May Benefit Cognition in MSPatients with multiple sclerosis who cut calories 2 days per week not only lost weight in a new study, they also showed better cognition and other positive outcomes.
Investigational MS Drug Safe, Effective at 18 MonthsThe potent, once-daily oral BTK inhibitor tolebrutinib showed encouraging safety and efficacy results in patients with multiple
sclerosis through 72 weeks in a new long-term extension of a phase 2b trial.
